Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-23-000783
Filing Date
2023-11-02
Accepted
2023-11-02 16:16:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3744
  Complete submission text file 0001971857-23-000783.txt   5330
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35890 | Film No.: 231372550
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Dubensky Thomas W. (Reporting) CIK: 0001635590 (see all company filings)

Type: 144